Clinical efficacy and cost‐effectiveness of metformin in different patient populations: A narrative review of real‐world evidence

Over the past two decades, diabetes pharmacopoeia has flourished, with new drugs that, on top of their glucose‐lowering efficacy, have been shown to protect the heart and the kidney. Despite these new opportunities, metformin retains a pivotal role among glucose‐lowering agents. As one of the few av...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes, obesity & metabolism obesity & metabolism, 2024-08, Vol.26 (S3), p.20-30
Hauptverfasser:	Solini, Anna, Tricò, Domenico
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidiabetics cardiovascular disease cost‐effectiveness analysis Diabetes Diabetes mellitus (non-insulin dependent) Glucose glucose lowering therapy Metformin Patients Population studies real world evidence type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!